Cargando…
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a**
Src homology 2 (SH2) domains play a central role in signal transduction. Although many SH2 domains have been validated as drug targets, their structural similarity makes development of specific inhibitors difficult. The cancer-relevant transcription factors STAT5a and STAT5b are particularly challen...
Autores principales: | Elumalai, Nagarajan, Berg, Angela, Natarajan, Kalaiselvi, Scharow, Andrej, Berg, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471549/ https://www.ncbi.nlm.nih.gov/pubmed/25702814 http://dx.doi.org/10.1002/anie.201410672 |
Ejemplares similares
-
Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
por: Elumalai, Nagarajan, et al.
Publicado: (2017) -
The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain
por: Gräb, Julian, et al.
Publicado: (2020) -
Stafia‐1: a STAT5a‐Selective Inhibitor Developed via Docking‐Based Screening of in Silico O‐Phosphorylated Fragments
por: Natarajan, Kalaiselvi, et al.
Publicado: (2019) -
Nanomolar-Potency Small Molecule Inhibitor of STAT5
Protein
por: Cumaraswamy, Abbarna A., et al.
Publicado: (2014) -
Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
por: Eckhardt, Katrin S., et al.
Publicado: (2022)